Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Urologic Oncology
Published October 17, 2026
Restricted mean survival time-based network meta-analysis of first-line therapies for metastatic ...
October 18, 2026
Medspoke
Medspoke
Urologic Oncology
Published October 17, 2026
00:00
--:--
Incidence and predictors of prolonged opioid use following nephrectomy for renal cell carcinoma: ...
October 18, 2026
Share
Incidence and predictors of prolonged opioid use following nephrectomy for renal cell carcinoma: A national claims-based study.
https://www.medspoke.co/channel_journal?id=689&tap_id=15872
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Urologic Oncology
Published October 18, 2026
Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer...
October 18, 2026
Why are you reporting this TALK?
